RedHill Biopharma Ltd (RDHL)

[midastouch017]

RedHill Biopharma to Present at the German Equity Forum 2016


TEL-AVIV, Israel, Nov. 16, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that Mr. Dror Ben-Asher, RedHill’s Chief Executive Officer, will present a corporate overview at the German Equity Forum 2016, on Monday, November 21, 2016, at 12:00 pm CET, at the Sheraton Frankfurt Airport Hotel and Conference Center, Frankfurt am Main, Germany.

A copy of the presentation to be made by Mr. Dror Ben-Asher is available on the Company's website and may be viewed at: http://ir.redhillbio.com.